Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Perianal Fistulas in Crohn's Disease: Surgical Closure vs Anti-TNF
2018-002064-15Phase 4Terminated
- Sponsor
- Academic Medical Center
- Start
- Apr 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of infliximab and adalimumab in Crohn's disease (2 arms), sponsored by Academic Medical Center. Primary endpoint: Proportion of patients with closed fistula (MRI based). Started Apr 2019; status: terminated.
02
Drugs
infliximabadalimumab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2018-002064-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002064-15.